Cross‐reactivity of a human IgG1 anticitrullinated fibrinogen monoclonal antibody to a citrullinated profilaggrin peptide
Open Access
- 17 October 2012
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 21 (12), 1929-1941
- https://doi.org/10.1002/pro.2178
Abstract
Rheumatoid arthritis (RA) is the most common autoimmune rheumatic disease. It is characterized by persistent joint inflammation, resulting in loss of joint function, morbidity and premature mortality. The presence of antibodies against citrullinated proteins is a characteristic feature of RA and up to 70% of RA patients are anticitrullinated protein antibody (ACPA) positive. ACPA responses have been widely studied and are suggested to be heterogeneous, favoring antibody cross-reactivity to citrullinated proteins. In this study, we examined factors that may influence cross-reactivity between a commercial human anticitrullinated fibrinogen monoclonal antibody and a citrullinated peptide. Using a citrullinated profilaggrin sequence (HQCHQEST- Cit-GRSRGRCGRSGS) as template, cyclic and linear truncated peptide versions were tested for reactivity to the monoclonal antibody. Factors such as structure, peptide length and flanking amino acids were found to have a notable impact on antibody cross-reactivity. The results achieved contribute to the understanding of the interactions between citrullinated peptides and ACPA, which may aid in the development of improved diagnostics of ACPA.Keywords
This publication has 41 references indexed in Scilit:
- Identification of continuous epitopes of HuD antibodies related to paraneoplastic diseases/small cell lung cancerJournal of Neuroimmunology, 2012
- The ACPA recognition profile and subgrouping of ACPA-positive RA patientsAnnals Of The Rheumatic Diseases, 2011
- Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damageProceedings of the National Academy of Sciences of the United States of America, 2011
- Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritisArthritis Research & Therapy, 2011
- Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritisArthritis Research & Therapy, 2011
- Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivitiesAnnals Of The Rheumatic Diseases, 2010
- Carbamylation-Dependent Activation of T Cells: A Novel Mechanism in the Pathogenesis of Autoimmune ArthritisThe Journal of Immunology, 2010
- Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritisThe Journal of Experimental Medicine, 2009
- Antibodies to citrullinated α‐enolase peptide 1 are specific for rheumatoid arthritis and cross‐react with bacterial enolaseArthritis & Rheumatism, 2008
- Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritisJCI Insight, 2006